In keeping with our roundtable format, we invited three thought-leaders to explore some of these dynamics. We created the question list below to capture not just the way in which the oncology business model is evolving, but also how the drug manufacturing industry needs to respond:
- List and describe the three biggest issues impacting the oncology business model.
- How are biopharmaceutical makers responding to these shifts? List and describe three essential strategies.
- What is the outlook for access to and quality of care over the next five years?
Bruce Cutter, MD, MMM. After many years of both patient care and leadership, Bruce is now a health care consultant. Key leadership accomplishments over the past ten years have included design and implementation of a community-based, integrated oncology delivery system, together with development, in close collaboration with a health plan, of a comprehensive quality initiative combined with a pay-for-quality contractual arrangement. Bruce is based in Spokane, WA.
Dawn Holcombe. Dawn, a private consultant, was recently Senior Vice President for Payer Relations and Quality Programs for both Supportive Oncology Services and its large network of affiliated oncology practices and the Cancer Clinics of Excellence, as well as Executive Director for the Oncology Network of Connecticut, LLC. Dawn's twenty-nine years in health care have included executive, strategic, financial, and marketing positions in academic and private health systems and physician practices. Dawn is based in South Windsor, CT.
John Engel, Esq. A founding partner of Engel & Novitt, LLP, John specializes in food and drug, public health, and administrative law, and health information technology and science policy and legislation. He provides strategic counseling on a wide range of legal and regulatory, intellectual property, and marketing initiatives affecting pharmaceutical, biotechnology, and medical device companies, as well as organizations representing health care professionals and their patients. John is based in Washington, DC.
Read article here.